Listed 55 pharmaceutical firms’ debts post 5.5 trillion won last year

Korea’s listed 55 drug firms’ debts stood at 5.53 trillion won last year, showing a slight increase from the previous year, an online business data provider said Monday.

In general, a high debt-to-equity ratio indicates that a company may not be able to generate enough cash to satisfy its debt obligations. However, low debt-to-equity ratios may also indicate that a company is not taking adv...